Development and Validation of an Innovative Analytical Approach for the Quantitation of Tris(Hydroxymethyl)Aminomethane (TRIS) in Pharmaceutical Formulations by Liquid Chromatography Tandem Mass Spectrometry

A novel COVID-19 vaccine (BriLife(®)) has been developed by the Israel Institute for Biological Research (IIBR) to prevent the spread of the SARS-CoV-2 virus throughout the population in Israel. One of the components in the vaccine formulation is tris(hydroxymethyl)aminomethane (tromethamine, TRIS),...

Descripción completa

Detalles Bibliográficos
Autores principales: Madmon, Moran, Shamai Yamin, Tamar, Pitel, Shani, Belay, Chen, Segula, Yaniv, Toister, Einat, Hindi, Ariel, Cherry, Lilach, Ophir, Yakir, Zichel, Ran, Mimran, Avishai, Diamant, Eran, Weissberg, Avi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822354/
https://www.ncbi.nlm.nih.gov/pubmed/36615269
http://dx.doi.org/10.3390/molecules28010073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822354/
https://www.ncbi.nlm.nih.gov/pubmed/36615269
http://dx.doi.org/10.3390/molecules28010073

Ejemplares similares